Skip to content

Life360, Inc. LIF Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value at other companies

LiveRamp Holdings, Inc. logo
LiveRamp Holdings, Inc.RAMP

Other financials

Income statement

See full
Revenue$143.1M+38.1%
Gross profit$110.6M+32.3%
Operating income-$8.1M-469%
Net income$2.8M-36.5%
EPS (diluted)$0.03-40.0%

Balance sheet

See full
Cash & equivalents$352.9M+107%
Total debt$263.0K-58.5%
Total equity$597.6M+58.8%
Total assets$1.0B+129%

Cash flow

See full
Operating cash flow$17.2M+42.7%
CapEx--100%
Free cash flow$17.2M+44.2%

Valuation

See full
Market cap$3.8B+12.9%

Profitability

See full
Gross margin77.1%+0.8pp
Operating margin1.6%
Net margin28.2%
FCF margin17.4%+9.2pp

Returns & leverage

See full
Return on equity30.6%
Debt / equity0.0×
Current ratio5.4×+2.0×

Where this comes from

Reported directly by Life360, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.

The official record: Life360, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Life360, Inc.'s share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Life360, Inc.'s share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value?
Life360, Inc. (LIF) reported share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value of $131.98M in Q1 2026.
How has Life360, Inc.'s share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value changed year-over-year?
Life360, Inc.'s share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value decreased by 20.0% year-over-year, from $165.06M to $131.98M.